by

MindScape Retreat Releases Landmark Case Study Showing 70% Average Symptom Improvement in Parkinson’s Patients Following Ibogaine Treatment in Mexico

Miami, FL, May 02, 2025 –(PR.com)– MindScape Retreat, a pioneer in clinical psychedelic therapy programs, has released the results of a transformative case series evaluating the safety and efficacy of a 14-day ibogaine treatment program for Parkinson’s disease. The findings suggest that ibogaine, a naturally occurring psychoactive alkaloid, may offer disease-modifying benefits in PD through its unique neuroregenerative properties.

The study tracked 30 patients with idiopathic Parkinson’s disease (PD), ...

Continue Reading →
Gavriel Dardashti Details Ibogaine Protocol Enhancements,
by

Gavriel Dardashti Details Ibogaine Protocol Enhancements,

PLANTATION, FL – April 30, 2025 – Representing Ibogaine by David Dardashti, Gavriel Dardashti will detail significant neuroscientific advancements enhancing ibogaine therapy protocols at the influential 2025 Psychedelic Conference in Denver, Colorado. Building on the foundational work of his father, founder David Dardashti, the presentation showcases how sophisticated technology refines and personalizes treatment, ...

Continue Reading →
by

Former Texas Governor And U.S. Senator Meet With State Lawmakers To Form National Ibogaine Access Plan

Drug policy reform advocates, public health experts and current and former government officials met for a summit in Colorado over the weekend to discuss how to move forward with state-led clinical research into ibogaine as a treatment for addiction, trauma and various neurodegenerative conditions.

Attendees at the three-day Aspen Ibogaine Meeting discussed science and policy around the plant-based psychedelic as well as how to go about building the necessary financial and legal infrastructure ...

Continue Reading →
Page 63 of 136 «...4050606162636465...»

Menu

Blog

Disclaimer

The information on this website is offered for informational use only. MYEBOGA specifically cautions against the use of iboga related products (i) in violation of the law, (ii) without appropriate professional guidance and monitoring, or (iii) without careful personal evaluation of potential risks and hazards. MYEBOGA specifically disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents of this website. This website does not promote ibogaine services in the R. O. Ireland.

About

This site is 100% voluntary and does not receive any form of payment from any of the providers listed here. In addition, this site does not engage in any way with the supply or manufacture of ibogaine or iboga related products or services. Information is offered for interest only and grew our of a desire to offer a service providing balanced information without any motive for profit.
UA-77446339-1